Connect Biopharma
(NASDAQ) CNTB
Connect Biopharma Financials at a Glance
Market Cap
$154.89M
Revenue (TTM)
$24.86M
Net Income (TTM)
-$22.07M
EPS (TTM)
-$1.15
P/E Ratio
-2.13
Dividend
$0.00
Beta (Volatility)
0.49 (Low)
Dividend
$0.00
Beta (Volatility)
0.49 (Low)
Price
$2.45
Volume
10
Open
$2.39
Price
$2.45
Volume
10
Open
$2.39
Previous Close
$2.46
Daily Range
$2.35 - $2.50
52-Week Range
$1.05 - $3.82
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
0.49 (Low)
Price
$2.45
Volume
10
Open
$2.39
Previous Close
$2.46
Daily Range
$2.35 - $2.50
52-Week Range
$1.05 - $3.82
Estimated Earnings Date
Aug 12, 2026
CNTB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Connect Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
64
CEO
Barry D. Quart, PharmD
Website
www.connectbiopharm.comHeadquarters
Taicang, 215400, CN
CNTB Financials
Key Financial Metrics (TTM)
Gross Margin
100.00%
Operating Margin
-60312.50%
Net Income Margin
-58350.00%
Return on Equity
-49.43%
Return on Capital
-136.10%
Return on Assets
-49.95%
Earnings Yield
-46.95%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$154.89M
Shares Outstanding
62.96M
Volume
10
Avg. Volume
312.22K
Financials (TTM)
Gross Profit
$24.86M
Operating Income
-$24.92M
EBITDA
-$21.16M
Operating Cash Flow
-$47.39M
Capital Expenditure
-$1.07M
Free Cash Flow
-$48.46M
Cash & ST Invst.
$44.34M
Total Debt
$690.00K
Connect Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$154.89M
N/A
Market Cap/Employee
$2.50M
N/A
Employees
62
N/A
Net Income
-$15.11M
+52.2%
EBITDA
-$14.90M
+57.8%
Quarterly Fundamentals
Total Cash
$44.34M
-62.5%
Total Debt
$690.00K
+48.4%
Accounts Receivable
$161.00K
-54.1%
Inventory
$0.00
N/A
Long Term Debt
$368.00K
+104.4%
Short Term Debt
$322.00K
+13.0%
Return on Assets
-49.95%
N/A
Return on Invested Capital
-68.18%
N/A
Free Cash Flow
-$11.27M
+33.1%
Operating Cash Flow
-$11.25M
+33.2%